News from Cytotheryx

Receive the Latest News from Us

Medical breakthroughs require innovative solutions, and Cytotheryx delivers. Learn more about our work from our latest news and updates.

Overview

Cytotheryx is a platform technology company solving for the limited supply of primary human hepatocytes currently used in drug discovery and disease-specific research, and supporting the development of new therapeutics for liver failure, liver disease, and rare diseases. We look forward to opportunities to share more about our work — and its benefits — with the life science community.

Contact Us

Looking for more information on our work? Get in touch with us. We’re always happy to discuss potential opportunities.

Anna Argo, Chief Business Officer
Tel: +1 (877) 275 2986
Email: anna.argo@cytotheryx.com

Read Our Latest Updates

Financing Update

Cytotheryx’s Series A financing, alongside strategic debt funding, will advance its cell therapy programs toward clinical development and support GMP manufacturing scale-up. Cytotheryx has opened

Read More »

Introducing Cytocine™: Primary Porcine Hepatocytes

Cytocine™ Cryopreserved Primary Porcine Hepatocytes offer a valuable alternative to human hepatocytes for preclinical research applications. With high viability, plateability, metabolic functionality, and scalability, Cytocine™ hepatocytes provide a reliable and cost-effective solution for researchers who need a consistent supply of cells for their experiments. Dive into our latest White Paper to learn more about this new source of high-quality liver cells to support biomedical research.

Read More »

Featuring Cytotheryx in Your Work?

Reach out to us! We’re open to conversations about our work, liver disease, and how a consistent, high-quality source of primary human hepatocytes will revolutionize the biomedical field as we know it. 

Download Our Press Kit

P.O. Box 7193 Rochester, MN 55903

+1-877-275-2986

©2023 Cytotheryx. All rights reserved.

Linkedin

P.O. Box 7193 Rochester, MN 55903

+1-877-275-2986

©2023 Cytotheryx. All rights reserved.

Linkedin